BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 28130617)

  • 1. Prolactin has a pathogenic role in systemic lupus erythematosus.
    Jara LJ; Medina G; Saavedra MA; Vera-Lastra O; Torres-Aguilar H; Navarro C; Vazquez Del Mercado M; Espinoza LR
    Immunol Res; 2017 Apr; 65(2):512-523. PubMed ID: 28130617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin in human systemic lupus erythematosus.
    Jara LJ; Vera-Lastra O; Miranda JM; Alcala M; Alvarez-Nemegyei J
    Lupus; 2001; 10(10):748-56. PubMed ID: 11721702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prolactin in connective tissue diseases].
    Parada-Turska J; Targońska-Stepniak B; Majdan M
    Postepy Hig Med Dosw (Online); 2006; 60():278-85. PubMed ID: 16715039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin as a modulator of B cell function: implications for SLE.
    Peeva E; Venkatesh J; Michael D; Diamond B
    Biomed Pharmacother; 2004 Jun; 58(5):310-9. PubMed ID: 15194167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A; Pascoe D; Fraga A; Blanco-Favela F
    Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated bioactive prolactin levels in systemic lupus erythematosus--association with disease activity.
    Pacilio M; Migliaresi S; Meli R; Ambrosone L; Bigliardo B; Di Carlo R
    J Rheumatol; 2001 Oct; 28(10):2216-21. PubMed ID: 11669159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-prolactin autoantibodies in paediatric systemic lupus erythematosus patients.
    Blanco-Favela F; Quintal MaG ; Chavez-Rueda AK; Leaños-Miranda A; Berron-Peres R; Baca-Ruiz V; Lavalle-Montalvo C
    Lupus; 2001; 10(11):803-8. PubMed ID: 11789490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus.
    Blanco-Favela F; Chavez-Rueda K; Leaños-Miranda A
    Lupus; 2001; 10(10):757-61. PubMed ID: 11721703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of systemic lupus erythematosus.
    Walker SE
    Lupus; 2001; 10(10):762-8. PubMed ID: 11721704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin and autoimmunity.
    Vera-Lastra O; Jara LJ; Espinoza LR
    Autoimmun Rev; 2002 Dec; 1(6):360-4. PubMed ID: 12848992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of prolactin and gonadotropin-releasing hormone in rheumatic diseases.
    Walker SE; Jacobson JD
    Rheum Dis Clin North Am; 2000 Nov; 26(4):713-36. PubMed ID: 11084941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolactin in murine systemic lupus erythematosus.
    McMurray RW
    Lupus; 2001; 10(10):742-7. PubMed ID: 11721701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin.
    Méndez I; Alcocer-Varela J; Parra A; Lava-Zavala A; de la Cruz DA; Alarcón-Segovia D; Larrea F
    Lupus; 2004; 13(1):45-53. PubMed ID: 14870917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2619-24. PubMed ID: 11397862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases.
    Neidhart M
    J Rheumatol; 1996 Mar; 23(3):476-81. PubMed ID: 8832986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin levels correlate with abnormal B cell maturation in MRL and MRL/lpr mouse models of systemic lupus erythematosus-like disease.
    Legorreta-Haquet MV; Flores-Fernández R; Blanco-Favela F; Fuentes-Pananá EM; Chávez-Sánchez L; Hernández-González R; Tesoro-Cruz E; Arriaga-Pizano L; Chávez-Rueda AK
    Clin Dev Immunol; 2013; 2013():287469. PubMed ID: 24454471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
    Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
    Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin modulates the disease activity of systemic lupus erythematosus accompanied by prolactinoma.
    Funauchi M; Ikoma S; Enomoto H; Sugiyama M; Ohno M; Hamada K; Kanamaru A
    Clin Exp Rheumatol; 1998; 16(4):479-82. PubMed ID: 9706433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.